Vanguard Personalized Indexing Management LLC Trims Stake in Solventum Corporation $SOLV

Vanguard Personalized Indexing Management LLC lessened its holdings in Solventum Corporation (NYSE:SOLV) by 9.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 15,061 shares of the company’s stock after selling 1,608 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Solventum were worth $1,176,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC lifted its position in Solventum by 140.6% in the first quarter. Farther Finance Advisors LLC now owns 1,821 shares of the company’s stock valued at $139,000 after buying an additional 1,064 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Solventum by 37.0% in the 1st quarter. GAMMA Investing LLC now owns 4,560 shares of the company’s stock worth $347,000 after acquiring an additional 1,231 shares during the last quarter. Sowell Financial Services LLC purchased a new position in shares of Solventum during the 1st quarter worth approximately $335,000. State of Alaska Department of Revenue increased its holdings in Solventum by 2.6% in the 1st quarter. State of Alaska Department of Revenue now owns 16,170 shares of the company’s stock valued at $1,229,000 after purchasing an additional 410 shares during the last quarter. Finally, Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Solventum during the first quarter worth $306,000.

Solventum Stock Performance

NYSE:SOLV opened at $72.11 on Friday. The firm has a market capitalization of $12.50 billion, a PE ratio of 33.38, a price-to-earnings-growth ratio of 2.94 and a beta of 0.50. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. The business’s fifty day moving average price is $72.63 and its 200 day moving average price is $71.95. Solventum Corporation has a 12 month low of $60.70 and a 12 month high of $85.92.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Thursday, August 7th. The company reported $1.69 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.24. Solventum had a return on equity of 29.93% and a net margin of 4.52%.The business had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. During the same quarter in the prior year, the business posted $1.56 EPS. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, sell-side analysts anticipate that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. UBS Group assumed coverage on Solventum in a report on Wednesday, October 1st. They issued a “neutral” rating and a $77.00 price objective on the stock. Wells Fargo & Company raised their price objective on shares of Solventum from $79.00 to $82.00 and gave the company an “equal weight” rating in a research note on Monday, September 15th. Jefferies Financial Group started coverage on shares of Solventum in a research note on Thursday, September 11th. They set a “hold” rating and a $80.00 target price on the stock. Piper Sandler reissued an “overweight” rating and issued a $94.00 price target (up previously from $87.00) on shares of Solventum in a research report on Friday, August 8th. Finally, Wall Street Zen downgraded shares of Solventum from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, September 9th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Solventum presently has a consensus rating of “Hold” and an average target price of $84.89.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.